Market Overview:
The global head and neck cancer drugs/therapeutics market is expected to register a CAGR of 7.8% during the forecast period (2018-2030). The growth in this market can be attributed to factors such as the increasing incidence of head and neck cancer, rising awareness about head and neck cancer treatments, and technological advancements in the field of oncology. Based on type, the global head and neck cancer drugs/therapeutics market is segmented into surgery, radiation therapy, chemotherapy, immunotherapy. Of these segments, radiation therapy is expected to witness highest growth during the forecast period owing to its high efficacy in treating various types of cancers including head and neck cancers. Based on application, the global head and neck cancer drugs/therapeutics market is segmented into hospital care settings and personal care settings. Hospital care settings are further sub-segmented into government hospitals & private hospitals while personal care settings are sub-segmented into homecare & ambulatory surgical centers (ASCs). The hospital care setting segment is estimated to account for a larger share of the global market in 2018 due to increased adoption rates for advanced therapies such as radiotherapy & chemotherapy among patients suffering from Head & Neck Cancer (HNC) across developed countries. However; with increasing preference for personalized healthcare among patients across emerging economies;the personal care setting segment is projected grow at a higher CAGR over the forecast period.
Product Definition:
Head and neck cancer drugs/therapeutics are medications or treatments used to treat head and neck cancer. Head and neck cancers include tumors that start in the mouth, nose, throat, or salivary glands. The most common types of head and neck cancers are squamous cell carcinoma (cancer that starts in the thin, flat cells that line the surfaces of organs) and lymphoma (cancer that starts in white blood cells).
Treatment for head and neck cancer may include radiation therapy, chemotherapy, surgery, targeted therapy (medications that attack specific features of cancer cells), or a combination of these treatment options. Head and neck cancer drugs/therapeutics play an important role in treating these cancers.
Surgery:
The global surgery, it's usage and growth factor in head and neck cancer drugs/therapeutics market size was valued at USD 1.8 billion in 2015. The increasing prevalence of oropharyngeal cancer is expected to be a high impact rendering driver for the growth of this market over the forecast period.
Radiation therapy:
Radiation therapy is the use of ionizing radiation, which is used to treat cancer. The types of cancers that can be treated with radiation include laryngeal, esophageal, gastric and liver as well as breast and lung carcinoma. Radiation oncology market includes external beam radiation therapy (EBRT), intraoperative radiotherapy (IRBT) and image-guided or robotic radiosurgery.
Application Insights:
The head and neck cancer drugs market is categorized based on application into hospital, personal care and others. The hospital segment dominated the overall industry in terms of revenue in 2017 owing to a large patient base for various cancers across the globe. Moreover, increasing R&D activities by major players coupled with rising awareness about early diagnosis is anticipated to boost growth over the forecast period.
The personal care segment is expected to witness lucrative growth during the forecast period due to growing consumer awareness regarding oral hygiene and its benefits along with an increase in spending capacity among consumers for better healthcare services including treatment of head and neck cancer.
Regional Analysis:
North America dominated the global head and neck cancer drugs/therapeutics market in 2017. This can be attributed to the high incidence of this disease, increasing prevalence of tobacco smoking, and availability of effective treatment methods for these patients. In addition, presence of key players such as Pfizer Inc.; Merck & Co., Inc.; Celgene Corporation; and AbbVie Inc., which are engaged in extensive R&D activities for new drug development is expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising healthcare expenditure by governments along with an increase in awareness regarding early diagnosis coupled with a rise in disposable income levels among individuals especially in India & China. Furthermore, growing medical tourism industry due to low cost treatment options offered by countries such as Japan are expected boost regional demand during the forecast period (2018-2030).
Growth Factors:
- Increasing incidence of head and neck cancer
- Rising demand for better treatment options
- Growing awareness about head and neck cancer among people
- Technological advancements in diagnosis and treatment of head and neck cancer
- increasing funding for research on head and neck cancer
Scope Of The Report
Report Attributes
Report Details
Report Title
Head and Neck Cancer Drugs/Therapeutics Market Research Report
By Type
Surgery, Radiation therapy, Chemotherapy, Immunotherapy
By Application
Hospital, Personal Care
By Companies
Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy’s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG, BioXpress
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Head and Neck Cancer Drugs/Therapeutics Market Report Segments:
The global Head and Neck Cancer Drugs/Therapeutics market is segmented on the basis of:
Types
Surgery, Radiation therapy, Chemotherapy, Immunotherapy
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospital, Personal Care
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Sanofi
- Eli Lilly
- Amgen
- Actavis
- Dr. Reddy’s Laboratories
- Jiangsu Hengrui
- Teva Pharmaceutical
- DFG
- BioXpress
Highlights of The Head and Neck Cancer Drugs/Therapeutics Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Surgery
- Radiation therapy
- Chemotherapy
- Immunotherapy
- By Application:
- Hospital
- Personal Care
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Head and Neck Cancer Drugs/Therapeutics Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Head and neck cancer drugs/therapeutics are medications used to treat head and neck cancer.
Some of the major companies in the head and neck cancer drugs/therapeutics market are Sanofi, Eli Lilly, Amgen, Actavis, Dr. Reddy’s Laboratories, Jiangsu Hengrui, Teva Pharmaceutical, DFG, BioXpress.
The head and neck cancer drugs/therapeutics market is expected to grow at a compound annual growth rate of 7.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Head and Neck Cancer Drugs/Therapeutics Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Head and Neck Cancer Drugs/Therapeutics Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Head and Neck Cancer Drugs/Therapeutics Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Head and Neck Cancer Drugs/Therapeutics Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Head and Neck Cancer Drugs/Therapeutics Market Size & Forecast, 2020-2028
4.5.1 Head and Neck Cancer Drugs/Therapeutics Market Size and Y-o-Y Growth
4.5.2 Head and Neck Cancer Drugs/Therapeutics Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Surgery
5.2.2 Radiation therapy
5.2.3 Chemotherapy
5.2.4 Immunotherapy
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospital
6.2.2 Personal Care
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Head and Neck Cancer Drugs/Therapeutics Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Head and Neck Cancer Drugs/Therapeutics Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Surgery
9.6.2 Radiation therapy
9.6.3 Chemotherapy
9.6.4 Immunotherapy
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospital
9.10.2 Personal Care
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Surgery
10.6.2 Radiation therapy
10.6.3 Chemotherapy
10.6.4 Immunotherapy
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospital
10.10.2 Personal Care
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Surgery
11.6.2 Radiation therapy
11.6.3 Chemotherapy
11.6.4 Immunotherapy
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospital
11.10.2 Personal Care
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Surgery
12.6.2 Radiation therapy
12.6.3 Chemotherapy
12.6.4 Immunotherapy
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospital
12.10.2 Personal Care
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Surgery
13.6.2 Radiation therapy
13.6.3 Chemotherapy
13.6.4 Immunotherapy
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospital
13.10.2 Personal Care
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Head and Neck Cancer Drugs/Therapeutics Market: Competitive Dashboard
14.2 Global Head and Neck Cancer Drugs/Therapeutics Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Sanofi
14.3.2 Eli Lilly
14.3.3 Amgen
14.3.4 Actavis
14.3.5 Dr. Reddy’s Laboratories
14.3.6 Jiangsu Hengrui
14.3.7 Teva Pharmaceutical
14.3.8 DFG
14.3.9 BioXpress
